2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of …

Katja Zeppenfeld, Jacob Tfelt-Hansen, Marta De Riva, Bo Gregers Winkel, Elijah R Behr, Nico A Blom, Philippe Charron, Domenico Corrado, Nikolaos Dagres, Christian De Chillou, Lars Eckardt, Tim Friede, Kristina H Haugaa, Meleze Hocini, Pier D Lambiase, Eloi Marijon, Jose L Merino, Petr Peichl, Silvia G Priori, Tobias Reichlin, Jeanette Schulz-Menger, Christian Sticherling, Stylianos Tzeis, Axel Verstrael, Maurizio Volterrani
2022-10-21
Abstract:4004 ESC Guidelines label use of medication should be limited to situations where it is in the patient’s interest to do so, with regard to the quality, safety, and efficacy of care, and only after the patient has been informed and has provided consent;(2) country-specific health regulations, indications by governmental drug regulatory agencies, and the ethical rules to which health professionals are subject, where applicable.
What problem does this paper attempt to address?